ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

437
Analysis
Health Care • South Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
bullish•Quantitative Analysis
•11 Dec 2019 05:03

Korea - Buyback Fuels Hyundai Motors Short Covering

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 6 December.Current...

Logo
524 Views
Share
bullish•Quantitative Analysis
•03 Dec 2019 17:40

Korea - Massive Covering on Hyundai Motor, Shorts Increase on SK Companies

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 29 November.Current...

Logo
666 Views
Share
bearish•Quantitative Analysis
•02 Dec 2019 16:06

Korea Shorts Data Analysis (#3): LG H&H, Amorepacific, KMW, Hotel Shilla, & DSINFRA

This is our third edition of the Korea Shorts Data Analysis. We broke down the Korean shorts data analysis that are available on KRX (data as of...

Logo
489 Views
Share
bearish•Cross Asset Strategy
•02 Dec 2019 08:47

One Simple Rule to Beat the Market in Korea - SAMSUNG

In this report, we provide one simple rule to beat the market in Korea, which is to stick with the Samsung Group.We want to state the...

Logo
414 Views
Share
bullish•Quantitative Analysis
•26 Nov 2019 17:44

Korea - Shorts Cover Hyundai Motor and Hyundai Mobis

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 22 November.Current...

Logo
546 Views
Share
x